ecancer

Testing the safety and efficacy of the PD-L1 antibody durvalumab

Dr Christophe Massard - Institut Gustave Roussy, Paris, France

6 Jun 2016

Patients with advanced bladder cancer benefit from anti-PD-L1 immunotherapy

Dr Arjun Balar - NYU Langone Medical Center, New York, USA

5 Jun 2016

Hypo-fractionation of prostate cancer radiotherapy

Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada

$Hypo-fractionation of prostate cancer radiotherapy ( Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada )$

3 Jun 2016

Understanding personalised medicine - the e-learning course

Prof Gordon McVie

4 May 2016

Physical activity may improve prostate cancer prognosis

Dr Ying Wang - American Cancer Society, Atlanta, USA

4 May 2016

Editor's Choice for April 2016

Prof Gordon McVie - ecancer Editor

29 Apr 2016

The UICC TNM Classification System: Free e-learning available now

Prof Gordon McVie - ecancer, Bristol, UK

21 Mar 2016

Editor's Choice for February 2016

Prof Gordon McVie - ecancer Editor

25 Feb 2016

What do healthcare providers think of the iManageCancer project?

Dr Dimitrios Papapaulou – Healthwatch Assistance, Thessalonika, Greece

15 Feb 2016

What do cancer charities think of the iManageCancer project?

Benedikt Geldmacher-Voss - Deutsche Kinderkrebsstiftung, Bonn, Germany

15 Feb 2016

iManageCancer: Serious games for self-management

Stefan Hoffmann - Serious Games Solutions, Potsdam, Germany

15 Feb 2016

iManageCancer: Psycho-emotional health and health assessment tools

Prof Gabriella Pravettoni – University of Milan and the European Institute of Oncology, Milan, Italy

15 Feb 2016

More from ecancer